索拉非尼作为挽救性治疗在难治复发性FLT3突变阳性急性髓系白血病中的临床应用研究

OBJECTIVE: To analyze the effect of sorafenib as salvage therapy used before and/or after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in refractory relapsed FLT3-positive acute myeloid leukemia (AML). METHODS: A total of 16 patients with refractory relapsed FLT3-positive AML, incl...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2016
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343102/
https://www.ncbi.nlm.nih.gov/pubmed/27093991
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.04.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343102/
https://www.ncbi.nlm.nih.gov/pubmed/27093991
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.04.009

Ejemplares similares